← Back to patent-cliff list
Phosphatidyl choline
Tier C — Watch / tradePhosphatidyl choline
University Of Heidelberg
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Mucoproteins
Indications (approved)：Submental fat accumulation, 耳鸣, Ulcerative colitis, 腹痛, Diarrhoea
Regional status
US
Unspecified clinical stage
2021-01-06
EU
Discontinued
2014-07-21
China
IND filed
2006-02-13
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Phosphatidyl choline?
Approved indications include: Submental fat accumulation, 耳鸣, Ulcerative colitis, 腹痛, Diarrhoea.
When does the Phosphatidyl choline patent expire?
No public expiry year is available for Phosphatidyl choline yet; this page updates once verified.
How do I get a quote for Phosphatidyl choline intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-21